• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经影像学的发展:正电子发射断层扫描。

Developments in neuroimaging: positron emission tomography.

机构信息

Pacific Parkinson's Research Centre, University of British Columbia & Vancouver Coastal Health. Vancouver, Canada.

出版信息

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S180-3. doi: 10.1016/S1353-8020(13)70042-7.

DOI:10.1016/S1353-8020(13)70042-7
PMID:24262176
Abstract

Positron emission tomography (PET) is a powerful technique to quantitatively assess brain function in vivo. In Parkinson's disease (PD), PET can assist in the identification of dopamine deficiency, the characterization of dopamine and other neurotransmitter receptors and transporters, serve as a biomarker and provide insights into motor and non-motor complications of PD. PET can also shed light on mechanisms that underlie disease, such as aberrant protein deposition and neuroinflammation. Emerging developments in multimodal imaging offer the opportunity to study multiple questions concurrently and offer great promise for the future.

摘要

正电子发射断层扫描(PET)是一种强大的技术,可定量评估体内大脑功能。在帕金森病(PD)中,PET 可协助识别多巴胺缺乏,描述多巴胺和其他神经递质受体和转运体,作为生物标志物,并深入了解 PD 的运动和非运动并发症。PET 还可以揭示疾病背后的机制,如异常蛋白沉积和神经炎症。多模态成像的新兴发展为同时研究多个问题提供了机会,并为未来带来了巨大的希望。

相似文献

1
Developments in neuroimaging: positron emission tomography.神经影像学的发展:正电子发射断层扫描。
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S180-3. doi: 10.1016/S1353-8020(13)70042-7.
2
Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.帕金森病的诊断优化:放射性核素成像
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S47-51. doi: 10.1016/j.parkreldis.2015.09.029. Epub 2015 Sep 15.
3
Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging.LRRK2 p.G2019S转基因大鼠的行为缺陷与纹状体多巴胺信号传导:包括PET神经成像的多模态研究。
J Parkinsons Dis. 2014;4(3):483-98. doi: 10.3233/JPD-140344.
4
Positron emission tomography in premotor Parkinson's disease.
Parkinsonism Relat Disord. 2007;13 Suppl 3:S421-4. doi: 10.1016/S1353-8020(08)70041-5.
5
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.携带LRRK2基因突变的帕金森病患者的正电子发射断层扫描:与散发性帕金森病的比较及症状前代偿的证据
Brain. 2005 Dec;128(Pt 12):2777-85. doi: 10.1093/brain/awh607. Epub 2005 Aug 4.
6
Central pharmacokinetics of levodopa: Lessons from imaging studies.左旋多巴的中枢药代动力学:影像学研究的启示。
Mov Disord. 2015 Jan;30(1):73-9. doi: 10.1002/mds.26046. Epub 2014 Oct 1.
7
The use of PET in Parkinson's disease.
Brain Cogn. 1995 Aug;28(3):297-310. doi: 10.1006/brcg.1995.1259.
8
In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.正电子发射断层扫描(PET)用(18)F-9-氟丙基-(+)-二氢四苯并嗪探测早期帕金森病中单胺能神经退行性变。
J Nucl Med. 2014 Jan;55(1):73-9. doi: 10.2967/jnumed.113.121897. Epub 2013 Nov 28.
9
Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study.帕金森病中多巴胺转运体与多巴胺更新率的关系:一项正电子发射断层扫描研究。
Ann Neurol. 2007 Nov;62(5):468-74. doi: 10.1002/ana.21204.
10
In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133.帕金森病中(18)F-AV-133 测定囊泡单胺转运体 2 密度的体内测量
J Nucl Med. 2010 Feb;51(2):223-8. doi: 10.2967/jnumed.109.070094. Epub 2010 Jan 15.

引用本文的文献

1
Characteristics and influencing factors of C-CFT PET imaging in patients with early and late onset Parkinson's disease.早发型和晚发型帕金森病患者C-CFT PET成像的特征及影响因素
Front Neurol. 2023 Jul 6;14:1195577. doi: 10.3389/fneur.2023.1195577. eCollection 2023.
2
PET Imaging in Movement Disorders.正电子发射断层扫描(PET)在运动障碍疾病中的应用
Semin Nucl Med. 2018 Nov;48(6):513-524. doi: 10.1053/j.semnuclmed.2018.07.006. Epub 2018 Aug 16.
3
DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers.
DaT-SPECT评估显示无症状G2019S LRRK2突变携带者存在多巴胺耗竭。
PLoS One. 2017 Apr 13;12(4):e0175424. doi: 10.1371/journal.pone.0175424. eCollection 2017.
4
Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.神经炎症与J2前列腺素:将泛素-蛋白酶体途径和线粒体的损伤与神经退行性变联系起来
Front Mol Neurosci. 2015 Jan 13;7:104. doi: 10.3389/fnmol.2014.00104. eCollection 2014.